Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4666-4672, Vol. 68, No. 8
Department of Infectious
Diseases1 and Department of
Pathology,2 Leiden University Medical
Center, Leiden, The Netherlands
Received 3 November 1999/Returned for modification 28 January
2000/Accepted 2 May 2000
The aim of this study was to investigate the effect of
interleukin-10 (IL-10) on the course of Listeria
monocytogenes infection in naive and immune mice. Treatment with
IL-10 during the course of a primary infection significantly decreased
the number of bacteria in the spleen and did not affect the number in
the liver. During a secondary infection in immune mice treated with
IL-10, the number of bacteria was significantly lower in the spleen but
significantly higher in the liver in comparison to mock-treated immune
mice. IL-10 treatment during a primary Listeria infection
decreased the concentration of gamma interferon (IFN-
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interleukin-10 Has Different Effects on
Proliferation of Listeria monocytogenes in Livers and
Spleens of Mice
) in plasma and
the toxoplasmastatic activity of macrophages, whereas it increased the
percentage of mildly CD3-positive T cells in the spleen. During a
secondary infection, the concentration of IFN-
in plasma was decreased on day 1 but remained unaffected during later days of infection. From these results, we conclude that IL-10 has different effects on the proliferation of L. monocytogenes in the
spleen and liver during primary and secondary Listeria infections.
*
Corresponding author. Present address: Free University,
Department of Cell Biology, Van der Boechorststraat 7, 1081 BT
Amsterdam, The Netherlands. Phone: 31.20.444 8077. Fax: 31.20.444 8080. E-mail: jn.samsom.cell{at}med.vu.nl.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»